Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder.
about
Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adultsPractitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescentsScreening for cardiovascular disease in the young.Attention-Deficit Hyperactivity Disorder and Long-QT Syndrome: Risky BusinessElectrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis.European guidelines on managing adverse effects of medication for ADHD.Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?Adult ADHD Medications and Their Cardiovascular ImplicationsBehavioral vaccines and evidence-based kernels: nonpharmaceutical approaches for the prevention of mental, emotional, and behavioral disorders.Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescentsSudden Cardiac Death in the YoungRisk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.Challenges in modelling the cost effectiveness of various interventions for cardiovascular disease.A conceptual framework for a long-term economic model for the treatment of attention-deficit/hyperactivity disorder.How to predict the impact of methylphenidate on cardiovascular risk in children with attention deficit disorder: methylphenidate improves autonomic dysfunction in children with ADHD.Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death.Heart rate variability and methylphenidate in children with ADHD.The early history of the neuroscience of attention-deficit/hyperactivity disorder.
P2860
Q26858868-D4F6C855-00CB-49BA-B64D-B70ADDE01151Q28282770-42680EF9-930C-4593-951B-45D3DB9BCD63Q30453075-BFD138D9-3F85-4662-9328-598E21DFA3A2Q33165891-CA4909EB-EFA4-403A-9D2F-EECBDC3987B1Q34258846-23E804E5-B1BD-4528-8D4B-F966C81F899FQ34448884-DF589C47-02D5-4579-9D98-7EA345EB8D26Q34461113-9F0ACB06-0C8A-452B-9B0D-9CED543D4952Q34539026-E072014C-FCA8-4410-9C50-0F372F63A20DQ34725155-43681878-063F-4AB6-8D92-2A6A5ADC45CEQ36002613-4597A743-2F7D-4605-8D5B-F1C8A2F873CFQ37275861-F623B612-9EBA-4944-87D6-6C8D74B5987CQ38060572-97833174-92D0-43F6-B5BA-9920A16D6414Q38205728-93897311-CD47-462C-A505-583331D6956FQ40425859-73807868-FAA7-4F9B-B930-28B810C0C04AQ41899976-E7B2F862-F3C4-415B-8091-A8E1301EB476Q44680690-7552AC00-C37F-4FE9-B54F-CFCEA04EED10Q46525843-CD587663-A12B-4C31-B016-ADBA15903384Q48418336-01038FFF-443F-4781-B1C8-80B11A1E5867
P2860
Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Modeled economic evaluation of ...... eficit/hyperactivity disorder.
@en
Modeled economic evaluation of ...... eficit/hyperactivity disorder.
@nl
type
label
Modeled economic evaluation of ...... eficit/hyperactivity disorder.
@en
Modeled economic evaluation of ...... eficit/hyperactivity disorder.
@nl
prefLabel
Modeled economic evaluation of ...... eficit/hyperactivity disorder.
@en
Modeled economic evaluation of ...... eficit/hyperactivity disorder.
@nl
P2093
P1433
P1476
Modeled economic evaluation of ...... eficit/hyperactivity disorder.
@en
P2093
Benedetto Vitiello
Jonathan R Kaltman
Michael Schoenbaum
Peter Denchev
P304
P356
10.1161/CIRCULATIONAHA.109.901256
P407
P577
2010-03-08T00:00:00Z